Genome-wide analyses identify KIF5A as a novel ALS gene

Aude Nicolas, Kevin Kenna, Alan E. Renton, ITALSGEN Consortium, Genomic Translation for ALS Care (GTAC) Consortium, Project MinE ALS Sequencing Consortium, NYGC ALS Consortium, Answer ALS Foundation, Clinical Research in ALS, Related Disorders for Therapeutic Development (CReATe) Consortium, SLAGEN Consortium, French ALS Consortium, Project MinE ALS Sequencing Consortium, et al., Karen Morrison

Research output: Contribution to journalArticlepeer-review

207 Citations (Scopus)


To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS.
Original languageEnglish
Pages (from-to)1268-1283.e6
Issue number6
Publication statusPublished - 21 Mar 2018


Dive into the research topics of 'Genome-wide analyses identify KIF5A as a novel ALS gene'. Together they form a unique fingerprint.

Cite this